|
CDER Meetings, Conferences and Webinars
FDA's Center for Drug Evaluation and Research (CDER) is holding several meetings, conferences and webinars over the upcoming months:
May
- May 9-10, 2022: FY 2022 Generic Drug Science and Research Initiatives Public Workshop
- May 11, 2022: SBIA | US-Canada Regional ICH Consultation
- May 11-12, 2022: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting
- May 16, 2022: FDA-ASCO Hematology and Oncology Fellows Day Workshop
- May 16-17, 2022: Pharmacokinetic Evaluation in Pregnancy- Virtual Public Workshop
- May 16-17, 2022: FDA CDER & NIH NCATS Regulatory Fitness in Rare Disease Clinical Trials Workshop
- May 24-25, 2022: SBIA | Quality Management Maturity Workshop
- May 24-25, 2022: FDA and Duke-Margolis Virtual Public Workshop - Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More
June
- June 3, 2022: Development Considerations of Antimicrobial Drugs for the Treatment of Uncomplicated Urinary Tract Infections (UTI)
- June 6-10, 2022: SBIA | Regulatory Education for Industry (REdI) Annual Conference 2022
- June 16, 2022: Conversations on Cancer: "National Black Family Cancer Awareness Week: Engaging the Generations”
Visit CDER's website for more information or to register.
|
